Moloney Securities Asset Management LLC Sells 2,084 Shares of Solventum Co. (NYSE:SOLV)

Moloney Securities Asset Management LLC cut its holdings in Solventum Co. (NYSE:SOLV) by 28.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,283 shares of the company’s stock after selling 2,084 shares during the period. Moloney Securities Asset Management LLC’s holdings in Solventum were worth $368,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Copeland Capital Management LLC bought a new position in shares of Solventum in the 3rd quarter worth about $26,000. Mather Group LLC. bought a new position in shares of Solventum in the 3rd quarter worth about $27,000. EverSource Wealth Advisors LLC bought a new position in shares of Solventum in the 1st quarter worth about $30,000. Hollencrest Capital Management bought a new position in shares of Solventum in the 2nd quarter worth about $25,000. Finally, Deseret Mutual Benefit Administrators bought a new position in shares of Solventum in the 2nd quarter worth about $25,000.

Analyst Ratings Changes

Several research analysts have recently weighed in on SOLV shares. Wolfe Research started coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. Stifel Nicolaus started coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Piper Sandler started coverage on Solventum in a research note on Monday, October 7th. They issued a “neutral” rating and a $71.00 target price for the company. Morgan Stanley reduced their target price on Solventum from $70.00 to $55.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th. Finally, BTIG Research started coverage on Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating for the company. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $64.33.

Solventum Stock Performance

Shares of NYSE SOLV opened at $74.14 on Thursday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05. The stock’s 50 day moving average price is $69.67 and its 200-day moving average price is $61.86. The company has a debt-to-equity ratio of 2.90, a quick ratio of 0.96 and a current ratio of 1.31.

Solventum (NYSE:SOLV) last announced its earnings results on Thursday, August 8th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.10. The business had revenue of $2.08 billion during the quarter, compared to analysts’ expectations of $2.05 billion. The business’s revenue was up .2% on a year-over-year basis. As a group, equities analysts predict that Solventum Co. will post 6.38 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.